SP1 and myeloproliferative disorder: Of the (NFE2, SP1 and NFKB1) targets upregulated in the non-BMP-activated HSCs, NFE2 is often overexpressed in the myeloproliferative disorders, which spontaneously transform to acute myeloid leukaemia and polycythemia23.